Cardiff Lexington Corp (CDIX) stock
CDIXOTCServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31
$0.04−0.01 (-25.53%)
Close on Oct 19, 2026Market cap $550.31KP/E –Yield –
Cardiff Lexington revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Cardiff Lexington's revenue for the twelve months ending Sep 30, 2026 was $9.07M, down 23.7% year over year. For fiscal 2025 it was $11.54M, up 39.5% from the year before. Over ten years it grew 23.6% a year on average. The highest annual figure on record is $11.85M in fiscal 2023.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.54M | +39.5% |
| FY2024 | Dec 31, 2024 | $8.27M | -30.2% |
| FY2023 | Dec 31, 2023 | $11.85M | +10.8% |
| FY2022 | Dec 31, 2022 | $10.69M | +8.2% |
| FY2021 | Dec 31, 2021 | $9.88M | +186.1% |
| FY2020 | Dec 31, 2020 | $3.45M | -6.9% |
| FY2019 | Dec 31, 2019 | $3.71M | +66.5% |
| FY2018 | Dec 31, 2018 | $2.23M | +37.0% |
| FY2017 | Dec 31, 2017 | $1.63M | +41.3% |
| FY2016 | Dec 31, 2016 | $1.15M | -17.2% |
| FY2015 | Dec 31, 2015 | $1.39M | +56.1% |
| FY2014 | Dec 31, 2014 | $890.40K | – |
| FY2013 | Dec 31, 2013 | $0 | -100.0% |
| FY2012 | Dec 31, 2012 | $839 | +220.2% |
| FY2011 | Dec 31, 2011 | $262 | -55.2% |
| FY2010 | Dec 31, 2010 | $585 | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $1.91M | -37.5% |
| Q2 FY2026 | Jun 30, 2026 | $2.16M | -22.6% |
| Q1 FY2026 | Mar 31, 2026 | $2.22M | -23.8% |
| Q4 FY2025 | Dec 31, 2025 | $2.77M | -11.2% |
| Q3 FY2025 | Sep 30, 2025 | $3.06M | +125.6% |
| Q2 FY2025 | Jun 30, 2025 | $2.79M | +89.5% |
| Q1 FY2025 | Mar 31, 2025 | $2.92M | +25.6% |
| Q4 FY2024 | Dec 31, 2024 | $3.12M | +31.3% |
| Q3 FY2024 | Sep 30, 2024 | $1.36M | -60.2% |
| Q2 FY2024 | Jun 30, 2024 | $1.47M | -56.3% |
| Q1 FY2024 | Mar 31, 2024 | $2.32M | -14.2% |
| Q4 FY2023 | Dec 31, 2023 | $2.38M | +72.0% |
| Q3 FY2023 | Sep 30, 2023 | $3.41M | +2.5% |
| Q2 FY2023 | Jun 30, 2023 | $3.36M | +8.8% |
| Q1 FY2023 | Mar 31, 2023 | $2.71M | -6.6% |
| Q4 FY2022 | Dec 31, 2022 | $1.38M | -60.0% |
| Q3 FY2022 | Sep 30, 2022 | $3.32M | +0.4% |
| Q2 FY2022 | Jun 30, 2022 | $3.09M | +41.6% |
| Q1 FY2022 | Mar 31, 2022 | $2.90M | +210.9% |
| Q4 FY2021 | Dec 31, 2021 | $3.45M | +336.8% |
| Q3 FY2021 | Sep 30, 2021 | $3.31M | +367.5% |
| Q2 FY2021 | Jun 30, 2021 | $2.18M | +119.7% |
| Q1 FY2021 | Mar 31, 2021 | $931.93K | -3.0% |
| Q4 FY2020 | Dec 31, 2020 | $790.91K | +4.7% |
| Q3 FY2020 | Sep 30, 2020 | $707.91K | -46.7% |
| Q2 FY2020 | Jun 30, 2020 | $993.51K | +5.2% |
| Q1 FY2020 | Mar 31, 2020 | $960.73K | +11.6% |
| Q4 FY2019 | Dec 31, 2019 | $755.14K | +7.9% |
| Q3 FY2019 | Sep 30, 2019 | $1.33M | +90.2% |
| Q2 FY2019 | Jun 30, 2019 | $944.80K | +68.5% |
| Q1 FY2019 | Mar 31, 2019 | $860.53K | +220.4% |
| Q4 FY2018 | Dec 31, 2018 | $699.54K | +238.3% |
| Q3 FY2018 | Sep 30, 2018 | $697.88K | +68.6% |
| Q2 FY2018 | Jun 30, 2018 | $560.86K | +0.1% |
| Q1 FY2018 | Mar 31, 2018 | $268.58K | -39.6% |
| Q4 FY2017 | Dec 31, 2017 | $206.76K | -28.5% |
| Q3 FY2017 | Sep 30, 2017 | $413.88K | – |
| Q2 FY2017 | Jun 30, 2017 | $560.49K | – |
| Q1 FY2017 | Mar 31, 2017 | $444.65K | – |
| Q4 FY2016 | Dec 31, 2016 | $289.16K | – |
See a number that looks wrong?